Clinical Trial Update: Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis [Phase 2]

View source ↗

Summary

Phase II trial evaluating topical bexarotene gel for parapsoriasis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parapsoriasis

Drugs mentioned

• bexarotene gel (bexarotene)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Parapsoriasis | Phase 2 | Status: TERMINATED